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Abstract 
An intergenic region of human Chromosome 2 (2p25.3) harbours genetic variants which are 
among those most strongly and reproducibly associated with obesity. The gene closest to 
these variants is TMEM18, although the molecular mechanisms mediating these effects 
remain entirely unknown. Tmem18 expression in the murine hypothalamic paraventricular 
nucleus (PVN) was altered by changes in nutritional state. Germline loss of Tmem18 in mice 
resulted in increased body weight, which was exacerbated by high fat diet and driven by 
increased food intake. Selective overexpression of Tmem18 in the PVN of wild-type mice 
reduced food intake and also increased energy expenditure. We provide new evidence that 
TMEM18 has four, not three, transmembrane domains and that it physically interacts with 
key components of the nuclear pore complex. Our data support the hypothesis that TMEM18 
itself, acting within the central nervous system, is a plausible mediator of the impact of 
adjacent genetic variation on human adiposity.  
 
Significance statement 
The growing size and sophistication of genome wide association studies has led to the 
identification of variants which are clearly and reliably associated with obesity. A strong 
association between increased BMI and a region of human chromosome 2, near to the gene 
TMEM18, has been repeatedly demonstrated in children and adults. The function of TMEM18 
in the control of appetitive behaviour and body composition has been poorly characterised. 
In murine models, we show germline loss results in weight gain while adult onset 
hypothalamic overexpression results in weight loss, supporting the hypothesis that TMEM18 
acting within the central nervous system can affect energy balance. We also report a novel 
structure and putative molecular function of TMEM18, challenging the current published 
model. 
 
 
 
 
 
\body 
INTRODUCTION 
The understanding of human obesity has benefited greatly from advances in molecular 
genetics.  In addition to the identification of many mechanistically illuminating, highly 
penetrant monogenic disorders, genome-wide association studies (GWAS) have identified 
multiple common genetic variants strongly associated with body mass index (BMI) (1-5).  
Many of these loci are within, or close to, genes which, to date, have not been recognised to 
encode proteins with a role in the control of energy homeostasis.  Of note, these genes show 
a strong preponderance to being highly expressed in the central nervous system, a finding 
which is congruent with the fact that monogenic disorders leading to obesity largely exert 
their effects through a disruption of the central control of appetite and energy balance (6). 
Murine models have proven to be highly useful in bridging the gap between the identification 
of a variant as being associated with an adiposity phenotype and the understanding of how 
that variant actually influences energy balance. For example, the robust correlation between 
BMI and polymorphisms in the first intron of the human fat mass and obesity-associated (FTO) 
gene has been followed by loss and gain of function studies in genetically modified mice 
supporting the notion that a number of neighbouring genes including IRX3 (which is the gene 
most likely mediating the effect of the human SNP), RPGRIP1L and FTO itself can all play a role 
in the control of energy balance and body composition (7-13). A strong association between 
increased BMI and a region of human chromosome 2, near to the gene TMEM18, has been 
repeatedly demonstrated in both adults and children (2, 14-18).  Like the genes in the  vicinity 
of FTO, TMEM18 had not been recognised as having a role in energy homeostasis prior to its 
identification by GWAS and relatively little is known about its function, save that it is 
expressed in the brain and that it encodes a 140 amino acid protein reported to contain three 
transmembrane domain (19) which may act as a DNA-binding protein (20).  We have 
therefore undertaken a range of studies to determine whether TMEM18 plays a role in the 
control of energy balance in mammals. 
RESULTS 
Tmem18 is expressed within hypothalamic paraventricular nucleus. We initially examined the 
expression pattern of Tmem18 in a range of murine tissues and two mouse hypothalamic cell lines (N-
46 and GT1-7).  In keeping with previous reports (19), Tmem18 was widely expressed, with expression 
observed in several regions of the brain, in brown adipose tissue and in both hypothalamic cell lines 
(Fig. S1). We undertook qPCR analysis on hypothalamic tissue acquired by laser capture microscopy 
(LCM) from 3 groups of wild type mice (ad libitum fed, 48 hr fasted and fasted for 48 hrs with leptin 
administered throughout the fast). 48 hr fasting decreased PVN Tmem18 expression by 70%, with 
leptin administration during the fast restoring expression back to fed levels (Fig. 1). To examine 
expression of Tmem18 in other hypothalamic nuclei and also to determine expression of the three 
genes vicinal to Tmem18 (Sh3yl1, Snth2 and Acp1), in a further set of wild type animals (either ad 
libitum fed or fasted for 24hrs) we undertook RNA Seq analysis of LCM-acquired tissue from four 
hypothalamic nuclei (arcuate, ventral medial, paraventricular and dorsal medial nuclei) (GEO 
accession number GSE96627, Fig. S2).  Tmem18 expression was observed in all nuclei examined. (Fig. 
S3).  Of note, in this data set of 24 hr fasting vs fed, none of the changes in expression of Tmem18, 
Sh3yl1, Snth2 or Acp1 reached statistical significance in any of the four nuclei studied (Fig. S4).  
Loss of Tmem18 expression results in an increase in body mass. Knockout mice carrying 
mutant allele Tmem18tm1a(EUCOMM)Wtsi (abbreviated to “Tmem18tm1a”) were generated on a 
C57BL/6 genetic background as part of the European Conditional Mouse Mutagenesis 
Program (EUCOMM) (21).  The introduction of the allele results in targeted disruption of exon 
2 of Tmem18.  Q-RT-PCR analysis revealed a very low level of residual Tmem18 transcript 
within the hypothalamus of homozygous mice (2.1% ±1.4), whilst heterozygous mice 
demonstrated a 50% decrease in transcript expression compared to Tmem18+/+ (49% ±9) (Fig. 
S5A).  Tmem18 was the only transcript at that locus to be altered by introduction of the allele 
(Fig. S5B) suggesting that there were no local ‘off target’ effects.  The mice were viable with 
expected homozygous mutant offspring born from heterozygous crosses. Female Tmem18tm1a 
homozygotes showed no differences in body weight or body composition compared to 
wildtype littermates (Fig.S6A, C and E). Male Tmem18tm1a homozygotes, on normal chow, had 
significantly increased body weight by 14 weeks of age (Fig. 2A) due to a significant increase 
in both fat and lean mass (Fig. 2C).  At 16 weeks, male homozygotes weighed on average 1.9 
g more than wildtype littermates and had both increased gonadal white adipose tissue 
(gWAT) and brown adipose tissue (BAT) mass (Fig. S7A). 
Male Tmem18 deficient mice fed a high fat diet become more obese because of an increase 
in food intake. To determine the effects of a high fat diet on weight gain in Tmem18 deficient 
mice, WT and homozygous Tmem18tm1a mice were switched from normal chow to a 45% fat 
diet (HFD) at 8 weeks of age.  Female Tmem18tm1a homozygotes on a HFD showed no 
differences in body weight or body composition compared to wildtype littermates (Fig. S6B, 
D and F).  However, male Tmem18tm1a homozygotes on a HFD displayed significantly increased 
body weight by 12 weeks of age (Fig. 2B) with an increase in both fat and lean mass (Fig. 2D).  
By 16 weeks of age male homozygotes on a HFD weighed ~4.1 g heavier than wildtype 
littermates and had both increased gWAT and BAT (Fig. S7B).  Food intake in these mice was 
assessed on two occasions, firstly over a 10-day period at 15 weeks of age whilst individually 
housed in home cages (Fig. 3A), and secondly over the 72hr period at 16 weeks of ages when 
mice were being analyzed for energy expenditure (Fig. 3B). On both occasions, Tmem18 
deficient mice consumed significantly more energy than wildtype littermates.  Interestingly, 
at the time of indirect calorimetry, Tmem18 deficient males on HFD had a significantly 
increased energy expenditure compared to wildtype littermates (ANCOVA analysis with 
correction for body weight differences, *p=0.015, Figs. 3C and 3D). Between genotypes, there 
was no difference in the expression of markers of thermogenesis in brown adipose tissue (Fig. 
S8A) or in activity levels (Fig. S8B).  Thus, the increase in food intake (13.9%) in animals lacking 
Tmem18 was partially compensated for by a rise in energy expenditure (7.0%), resulting in 
only a modest increase in weight.  
Overexpression of Tmem18 within the PVN reduces food intake and increases energy 
expenditure. Having determined that Tmem18 expression in the PVN was altered by changes 
in nutritional state, we used adeno-associated viral vector (AAV-T18) to manipulate 
expression of Tmem18 within the PVN and study subsequent effect on feeding behaviour and 
body weight.  Having confirmed targeting studies using AAV over-expressing GFP (Fig. S9A), 
we then performed bilateral injections of an AAV-Tmem18-cDNA into the PVN of 12 week old 
C57/BL6 male mice. Compared to control mice, mice who received vectors expressing 
Tmem18 cDNA had a significant two-fold increase in expression level (Fig. 4A). We found a 
significant difference in body weight gain at 2 weeks post-surgery and by 6 weeks, mean 
weight gain in mice overexpressing Tmem18 was only 0.9 g compared to a 2.7 g in the control 
group ( absolute weight gain; Fig. 4B: percentage weight gain; Fig. 4C). Analysis of food intake 
at 2 weeks post-surgery demonstrated AAV-T18 treated mice to have a significant reduction 
in food intake which was likely to have contributed to their reduction in weight gain (Fig. 4D). 
Interestingly, when re-assessed at 6 weeks, this relative hypophagia appeared to have 
resolved with no difference in energy intake between genotypes (Fig. 4E).  However, at 6 
weeks post-surgery there was a significant difference in energy expenditure with AAV-T18 
treated mice showing an increase compared to the control group (Fig. 4F, ANCOVA analysis 
with correction for body weight differences, *p=0.03).Additionally, a separate group of mice 
(n=6) over-expressing Tmem18 were placed on a high fat diet immediately after stereotactic 
surgery.  Again, mice over-expressing Tmem18 gained significantly less weight (Fig. S9D).  
There was a trend for a reduction in energy intake at 2 weeks (Fig. S9E) and at 6 weeks there 
was a significant difference in both total and fat mass between groups (Fig. S9F). 
TMEM18 contains four, not three, transmembrane domains TMEM18 has been described to 
be a three transmembrane protein that localizes to the nuclear membrane, courtesy of a 
nuclear localization signal, and reported to be involved in transcriptional repression (19, 20).  
To test this hypothesis, we first embarked on a deep phylogenetic analysis exploring sequence 
profile-to-profile homology (22) with MPI Bioinformatics Toolkit software (23).  Database 
searches revealed remote but clear homology of TMEM18 to various ion channels.  These 
included proteins from Pfam families (http://pfam.xfam.org) of fungal transient receptor 
potential ion channels (PF06011) and bacterial mechanosensitive ion channels (PF12794).  
Searches in metazoan proteomes yielded Unc-93 A homologues (mammalian 
gene UNC93A) annotated in C. elegans as an ion channel. The top hits (Toolkit parameter of 
probability of true positives about 80%) comprised a voltage-gated sodium channel 
from Caldalkalibacillus thermarum and an ion transport protein from Arcobacter butzleri 
(PDB identifiers 4bgn and 3rvy).  Although their mutual phylogenetic distances are remote, 
they fold into a very similar structure and TMEM18 shares suggestive homology with their 
ion-transmitting domain.  This region forms an oligomer consisting of two N- and C-terminal 
transmembrane helices pointing to the cytoplasm and two shorter inner helices fully 
embedded in the membrane.  The conserved charged tip of their C-terminal helices is entirely 
outside the membrane and participates in the pore opening.  It is highly probable that 
TMEM18 possesses a very similar topology and structure.  Based on the homology to the C. 
thermarum channel, a tentative model can be proposed.  Fig. S10 shows the modelled 
membrane topology and a putative 3D structure under the assumption that TMEM18 forms 
a tetramer similar to the A. butzleri channel (24).  As a nuclear membrane protein, it should 
expose both its termini to the cytoplasm and therefore would be comprised of four, rather 
than three, transmembrane domains.  To test this experimentally we transfected Cos cells 
with a N-terminal FLAG-tagged Tmem18 construct then detected protein expression using 
either a FLAG antibody or a TMEM18 antibody raised against C-terminus amino acids 120-
134.  Protein expression was analyzed using two different detergents, TX100 that 
permeabilises all cellular membranes and digitonin, that only permeabilises the plasma 
membrane at a concentration of 40ug/ml.  Control antibodies (lamin B and calnexin) gave the 
expected results.  Lamin B, which is localized to the inside of the nuclear membrane could 
only be detected when TX100 was used to permeabilise both the plasma and nuclear 
membrane (Fig. S11A & B) whereas calnexin, which spans the nuclear membrane with the 
C-terminus pointing into the cytoplasm, could be detected with both permeabilisation 
reagents using a C-terminal antibody (Fig. S11C & D).  Both the N-terminus (FLAG antibody, 
Fig. 5A & 5B) and C-terminus (TMEM18 antibody, Fig. 5C & 5D) of TMEM18 could be detected 
with digitonin permeabilisation indicating that both ends of the protein were located within 
the cytoplasm and confirming the bioinformatics analysis which suggested that TMEM18 is a 
four transmembrane protein.  
TMEM18 is unlikely to directly regulate transcription It has been suggested that TMEM18 
binds DNA and supresses transcription (20).  To test this hypothesis, we performed RNA-Seq 
analysis of hypothalami from wildtype and Tmem18 knockout male mice (ENA accession 
PRJEB13884).   Altogether, 27691 (27727 with non-zero total read count; 36 outliers per cooks 
Cutoff (25)) annotated genes had reads mapped in at least one sample and were used for 
differential expression analysis (average number of uniquely mapped reads per sample: 
32.4x10-6 ± 2.04x10-6 SD).  Interestingly, after adjustment for multiple testing, only Tmem18 
was significantly differentially expressed within the hypothalami of the two genotypes (padj 
= 3.02 x 10-22, Fig. S12A).  Q RT PCR analysis of Tmem18 and six additional genes with smallest 
(but not statistically significant) padj values confirmed the RNAseq data (Fig. S12B), suggesting 
that TMEM18 is unlikely to be a global regulator of transcription as previously reported (20). 
TMEM18 interacts with two nuclear pore proteins, NDC1 and AAAS We used the methods 
of affinity purification and mass spectrometry (26) to identify novel TMEM18 interacting 
partners.  Either FLAG-tagged TMEM18 or empty FLAG vector were over expressed in HEK293 
cells.  Protein complexes were immunoprecipitated using a FLAG antibody and mass 
spectrometry analysis performed to detect proteins bound to TMEM18.  This process 
identified 116 proteins pulled down in control cells expressing the empty FLAG vector, 221 
proteins common to both the control and experimental group, and 244 proteins unique to 
cells expressing FLAG-TMEM18 (See Supplementary Table 1 for a list of all proteins identified 
as being pulled down by FLAG-TMEM18).  Interestingly, three members of the nuclear pore 
complex, NDC1, AAAS and NUP35/53 (27) showed high numbers of assigned spectra 
indicating a high abundance of these proteins after pulldown.  Therefore, biomolecular 
immunofluorescence complementation (BiFC) assays were employed to confirm interactions 
between these proteins and TMEM18.  Controls behaved as expected and showed that no 
YFP expression was seen if YN constructs were co-transfected with a YC-STOP plasmid (Fig. 
6A).  YN-FLAG-NDC1 and YC-AAAS served as an appropriate positive control (Fig. 6B) as these 
proteins have been reported to interact previously (28, 29).  YFP expression could be detected 
in cells expressing YC-TMEM18 and either YN-FLAG-NDC1 or YN-FLAG-AAAS; but not YN-FLAG-
NUP35 (Fig. 6C-G).  Positive BiFC protein-protein interactions were corroborated further by 
co-immunoprecipitation experiments using FLAG-TMEM18 and either GFP tagged NDC1 (Fig. 
6H) or GFP tagged AAAS (Fig. 7I). 
DISCUSSION 
Our data indicate that altering Tmem18 expression in mice, both globally and within the 
hypothalamus, can alter body weight.  Male mice with a germline loss of Tmem18 have an 
increased body weight due to a significant increase in both fat and lean mass.  This phenotype 
is more pronounced on a high fat diet, where weight gain is driven by hyperphagia.  In 
contrast, overexpression of Tmem18 expression within the hypothalamic PVN can reduce 
food intake, increase energy expenditure and reduce both total body and fat mass.  The 
increased body weight phenotype of Tmem18 null mice was sexually dimorphic.  Sex-specific 
differences in metabolic studies focusing on body weight are not uncommon and have been 
seen, for example, after embryonic TrkB inhibition or with disruption of GABA receptor 
signalling in proopiomelanocortin neurons (30, 31).  In these reports and in our current study 
data, the mechanisms behind the sex-specific changes in body weight remain to be fully 
determined but the differences in circulating gonadal derived hormones remain, of course, a 
potential contributor.  Indeed, the relevance of oestrogen in influencing the response to a 
dietary intervention was highlighted again in a study by Dakin et. al. in which oestradiol 
treatment to male mice fed a high-fat, high-sugar ‘obesogenic' diet prevented increases in 
adipose tissue mass (32). 
Male mice on a high fat diet gained weight because of increased energy intake.  Of note, data 
from indirect calorimetry also showed Tmem18 null mice to have a ~10% increase in energy 
expenditure compared to wild type mice, but as food intake was increased by ~30% the 
dominant drive was to caloric excess and weight gain.  This could be considered an example 
of “diet induced thermogenesis”, a state seen as an effect of a change to a higher calorie diet 
in which mice increase energy expenditure and food intake simultaneously (33). The potential 
biological purpose and the tissues relevant to this phenomenon continue to be disputed (34). 
There is more agreement that the ambient temperature of a study can have a strongly 
qualitative effect on the outcome of metabolic studies (35).  Our studies were conducted 
under “standard” animal house conditions that could be considered a chronic thermal stress 
to mice. Future studies of energy expenditure in Tmem18 deficient mice living at 
thermoneutrality may be helpful in further understanding the role of this molecule in 
metabolic control.  
Several groups have previously shown Tmem18 to be highly expressed within the 
hypothalamus, although not all have reported it to be nutritionally regulated (19, 36, 37). Our 
data also indicate that Tmem18 is expressed within a number of hypothalamic regions. We 
chose  to focus on the PVN, an anatomical region enriched with neuronal populations involved 
in appetitive behaviour and energy expenditure (38) and one in which we saw nutritional 
regulation.  The character of Tmem18 expressing neurons within the PVN remain to be 
determined. Further, the nature of the different perturbations (germline loss in Tmem18tm1a 
vs delivery of AAV via stereotactic injection) is likely to mean that the PVN neuronal 
population which lost Tmem18 expression in the null mice may not be the same population 
that gained overexpression in the stereotactic-driven AAV study.  We were unfortunately 
unsuccessful in our attempts to use siRNA and Cre to selectively knock down and/or delete 
Tmem18 in the PVN despite promising preliminary studies in vitro.  In the future, transgenic 
lines with specific anatomical Cre drivers (e.g. Sim1-Cre, Agrp-Cre) may be helpful to further 
delineate the role of TMEM18 in both hypothalamic nuclei and specific neuronal populations.  
We report interesting new data on the potential function of TMEM18.  Previous reports have 
indicated that TMEM18 is highly conserved, has no family members, localizes at the nuclear 
membrane and that the C-terminus of the protein may be involved in the regulation of 
transcription.  Whilst the localization of TMEM18 is not disputed we propose that a role for 
TMEM18 in transcriptional regulation is unlikely given our RNA-Seq data showing that the 
hypothalamic transcriptome of Tmem18tm1a mice is not significantly different to that of 
wildtype littermates.  Previous bioinformatic analysis had predicted a 3 transmembrane 
structure (19, 39). However, our cellular experiments reveal that TMEM18 is in fact comprised 
of four transmembrane segments indicating that it is unlikely that the C-terminus is involved 
in binding DNA as earlier reported (20).  Instead we hypothesise that TMEM18 may be 
involved in the transport of molecules across the nuclear envelope.  Pull-down experiments, 
corroborated by BiFC and IP studies have identified two novel binding partners for TMEM18 
– NDC1 and AAAS/ALADIN.  These proteins are two of the thirty NUPs that make up the 
nuclear pore complex (NPC) (40).  As NDC1 and AAAS have previously been reported to 
interact with one another (29) it is possible that TMEM18 is not interacting directly with both 
proteins.  By enabling transport of molecules across the nuclear envelope, NUPs are involved 
in many fundamental cellular processes, consequently abnormal expression/function of these 
NUPs has been linked to various human diseases such as cancer, cardiovascular disorders, 
autoimmune disease and neurological defects (41).  Further investigation into the interaction 
of TMEM18 with members of the NPC will hopefully shed new light on the molecular function 
of TMEM18 and its role in obesity. 
The association of single nucleotide polymorphisms (SNPs) near human TMEM18 with obesity 
was first reported by Willer et al. (2) and has since been identified by multiple GWAS 
(reviewed in (6)). Although these loci have taken on the moniker of ‘near to TMEM18’, to date 
it has remained unclear whether these variants have any influence on the regulation of 
TMEM18 expression or function, or indeed if TMEM18 has a direct role in energy homeostasis. 
Efforts to advance understanding from association to biologically relevant mechanisms have 
combined multiple techniques and evidence from several model platforms.  For example, 
when investigating obesity-associated noncoding sequences within FTO, Smemo used 
chromatin conformation capture techniques (CCST) to show a region of FTO directly interacts 
with, and forms part of the regulatory landscape of, the homeobox gene IRX3 (10).  They also 
reported that relevant SNPS were associated with expression of IRX3, but not FTO, in human 
brains.  In a more recent study of obesity associated FTO variants, Claussnitzer combined 
chromatin capture technology, eQTL data and a powerful bioinformatics approach to 
investigate a putative role for FTO adipocyte biology (42). Thus far our attempts to interrogate 
the region near TMEM18 through the examination of various gene expression databases 
shows no eQTL data relevant to these SNPs. Further, our data are insufficient to confirm or 
refute a role for other genes vicinal to TMEM18 as candidates of the GWAS association. A 
brain tissue specific approach may prove more fruitful but unfortunately RNA expression data 
specifically from human hypothalamus linked to genotype is not a currently publicly available 
resource. The studies we have described have strengthened the candidacy of TMEM18 as, at 
least in part, the mediator of the association between genetic variation in this region of 
chromosome 2 and human adiposity, one of the strongest associations of a common variant 
with human obesity.  Our work has also provided novel information about the topology and 
binding partners of this enigmatic protein associated with the nuclear pore complex. 
METHODS 
Detailed study methods are provided in SI appendix 
Animals. All procedures were carried out in accordance with guidelines of the United 
Kingdom Home Office.  Animals were kept under controlled temperature (22oC) and a 12-h 
light, 12-h dark schedule (lights on 7:00–19:00).  
AAV Vectors. The cDNA of murine Tmem18 was cloned into an AAV backbone plasmid under 
the control of the CMV promoter. AAV vectors were generated by helper virus-free 
transfection of HEK293 cells.   
Stereotactic surgery. Mice were stereotaxically injected with AAV while under isoflurane 
induced anaesthesia (coordinates; 1.0 mm caudal to bregma, ±0.25 mm lateral to the midline, 
5.0 mm below the surface of the skull).  
Metabolic phenotyping. Body composition was determined using Lunar PIXImus2 mouse 
densitometer (General Electric Medical Systems, Fitchburg, WI).Energy expenditure was 
determined using indirect calorimetry in a custom built monitoring system (Ideas Studio, 
Cambridge, UK).   
Laser capture microdissection Coronal sections of 20 um thickness were prepared on a 
cryostat, mounted on RNase-free membrane-coated glass slides with laser microdissection 
performed using a P.A.L.M. MicrolaserSystem (P.A.L.M. Microlaser Technologies).  
Pulldown and Mass Spec analysis.  For protein over expression studies, transient transfection 
in HEK293 cells was performed using a CalPhos kit according to the manufacturer’s protocol.  
48 hours post transfection, cells were harvested and Flag immunoprecipitations (IPs) were 
performed from the resulting lysates.   
Statistical Analysis. All values are expressed as mean ±S.E.M.  Statistical analysis was 
performed using Graph Pad Prism software (GraphPad Prism) or SPSS (IBM).  For the analysis 
of food intake and body weight over time, two-way repeated measures ANOVA, with a 
Bonferroni post-test, was used with time and treatment as variables for comparison.  For 
energy expenditure (EE) analysis of covariance (ANCOVA) was performed to assess body 
weight/EE interactions with body weight as a covariate, genotype or AAV treatment as a fixed 
factor and EE as a dependent variable.  Multiple linear regression analysis was carried out 
with no selection criteria. Differential expression in LCM tissue analysis was calculated using 
edgeR, with correction for multiple comparisons using the Benjamini-Hochberg procedure. 
Significant differences were designated as p < 0.05. 
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Figure legends  
Fig. 1. Tmem18 expression within the hypothalamic paraventricular nucleus is nutritionally 
regulated.  Q-RT-PCR analysis showing changes in Tmem18 gene expression in the PVN of 
wildtype mice that have been fed, fasted for 48hrs or fasted for 48hrs with leptin 
administration. Data are expressed as mean ± SEM; * p<0.05, ** p<0.01 vs fasted mice. 
Fig. 2. Germline loss of Tmem18  results in increased body weight in male mice.  Body weights 
of Tmem18 wt/wt (WT) and Tmem18 tm1a/tm1a (HOM) male mice on (A) normal chow from 
weaning (WT, n=23; HOM, n=23) or (B) high fat diet (HFD) from 8 weeks of age (WT, n=15; 
HOM, n=20). Body composition analyses showing total, lean or fat mass of 14‑week old WT 
and HOM male mice on (C) normal chow (WT, n=16; HOM, n=16) or (D) HFD from 8 weeks of 
age (WT, n=18; HOM, n=20). Data are expressed as mean ± SEM; * p<0.05, ** p<0.01, *** 
p<0.001 vs WT mice. 
Fig. 3. Effect of loss of expression of Tmem18 on energy homeostasis, activity levels and food 
intake in male mice fed a HFD. Average 24-hour energy intake of WT and homozygous male 
mice both (A) measured in their home cage and (B) measured in the indirect calorimetry cage. 
(C) ANCOVA analysis of 24-hour energy expenditure (EE) with body weight at time of analysis. 
(D) Average bodyweight of individual animals during 72hr analysis of energy expenditure.  For 
all panels WT n=13, HOM n=18. Data are expressed as mean ± SEM;* p<0.05, ** p<0.01 vs WT 
mice.   
Fig. 4. Overexpression of Tmem18 within the PVN.  (A) Change in Tmem18 gene expression 
within the PVN of mice 7 weeks after bilateral injection of an adeno‑associated‑vector (AAV-
T18) (n= 10-11).  Change in body weight of mice, measured weekly for 6 weeks after bilateral 
PVN injections with either an AAV-T18 cDNA or AAV-GFP (n=15 each group), expressed as 
grams (B) and as percentage of starting body weight (C). (D) Average 24-hour energy intake 
of mice, measured in their home cage, 2 weeks post-surgery (n=15 each group). (E) Average 
24‑hour energy intake of mice, in the indirect calorimetry cage, 6 weeks post-surgery (n=13 
each group). (F) ANCOVA analysis of total energy expenditure (EE), assessed over a 24-hour 
period 6-weeks post injection, with covariates evaluated at body weight=29.41g (n=13 each 
group). Data are expressed as mean ± SEM,* p<0.05, ** p<0.01, *** p<0.001 vs GFP injected 
mice. 
Fig. 5. Topology of the TMEM18 protein. (A-D) Over-expression of N-terminal FLAG-tagged 
TMEM18 in COS cells treated with either TX-100 (permeabilises both plasma & nuclear 
membrane) or digitonin (permeabilises plasma membrane only).   TMEM18 expression was 
detected with either a FLAG antibody (red, A&B) or an antibody to the C-terminus of TMEM18 
(green, C&D). 
Fig. 6. BiFC and co-IP confirmation of TMEM18 interaction with NDC1 and AAAS (A-G) Physical 
interaction between TMEM18 and NDC1 and AAAS was confirmed by BiFC.  The N-terminus 
of YFP was fused to FLAG-tagged NDC1 (YN-F-NDC1, panel C) or AAAS (YN-F-AAAS, panel E) or 
NUP35 (negative control, YN-F-NUP35, panel G), while the C-terminus of YFP was fused to 
TMEM18 (TMEM18-Yc).  FLAG expression was detected using a FLAG antibody (red) while YFP 
signal is depicted in green.  YN-F-NDC1 and AAAS-YC was used as a positive BiFC control (panel 
B).  (H and I) Co-immunoprecipitation experiments using FLAG-tagged TMEM18 and 
GFP-tagged NDC1 (H) or AAAS (I) overexpressed in HEK cells. Dashed lines in the blot 
represents two different lanes in the same blot put together. 
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SUPPLEMENTARY INFORMATION 
SI METHODS 
Animals. All procedures were carried out in accordance with guidelines of the United Kingdom Home 
Office.  Animals were kept under controlled temperature (22oC) and a 12-h light, 12-h dark schedule 
(lights on 7:00–19:00). Standard chow (Special Diet Services, SDS) or a 45% fat diet (D12451, SDS) and 
water were available ad libitum.  Mice carrying the knockout first conditional-ready allele 
Tmem18tm1a(EUCOMM)Wtsi, abbreviated to Tmem18tm1a in this paper, were generated on a C57BL/6N 
background as part of the Sanger Mouse Genetics Project (MGP) for the European Conditional Mouse 
Mutagenesis Program [EUCOMM]. Detailed description of the Sanger Mouse Genetics Project 
methodology has previously been reported (1-4). Germ line transmission was confirmed by a series of 
genotyping PCR analyses (http://www.knockoutmouse.org/kb/25/). Following confirmation, mice 
derived from heterozygous inter cross, were genotyped for the Tmem18tm1a allele by PCR. 
Tmem18flox/flox mice (Tm1c line) were generated by crossing Tmem18tm1a mice to a Flpase deleter line 
on the same genetic background (5).   
Design and Construction of AAV Vectors. To generate a Tmem18 expressing adeno associated viral 
(AAV) vector, the cDNA of murine Tmem18 was cloned into an AAV backbone plasmid under the 
control of the CMV promoter. AAV vectors expressing GFP under the control of the same promoter 
were used in a control group of animals as well as to test for optimum titre and accuracy of 
intranuclear injections in preliminary experiments. 
Viral production and purification. AAV vectors were generated by helper virus-free transfection of 
HEK293 cells using three plasmids. Vectors were purified by two consecutives caesium chloride 
gradients using an optimized method (6), dialyzed against PBS, filtered, titred by qPCR and stored at -
80oC until use. This study used AAV serotype 7. 
Stereotactic surgery. Mice were stereotaxically injected with AAV while under isoflurane induced 
anaesthesia. The coordinates used for the injections were 1.0 mm caudal to bregma, ±0.25 mm lateral 
to the midline and 5.0 mm below the surface of the skull in all cases. Using a 10μl Hamilton syringe 
and a 33 gauge needle, 200nl of AAV solution was injected into each side of the hypothalamus over a 
1 minute period. After delivery of the virus the needle was left in place for 10 minutes to prevent 
reflux. The titre of the vector preparations were as follows: AAV7-CMV-GFP 2.1x1012vg/ml (dose 
delivered per 200nl 4x107vg); AAV7-CMV-Tmem18 6.3x1012vg/ml (dose delivered per 200nl 
1.2x108vg).  
Metabolic phenotyping.  Body weight measurements were recorded on a weekly basis. Food intake 
studies were carried out on single housed animals in home cages. Daily food intake was an average 
taken from 10 consecutive days. Body composition was determined using dual-energy x-ray 
absorptiometry (DEXA) (Lunar PIXImus2 mouse densitometer, General Electric Medical Systems, 
Fitchburg, WI). Any animal who did not remain weight stable did not proceed to calorimetry. Energy 
expenditure was determined using indirect calorimetry in a custom built monitoring system at 20oC 
(Ideas Studio, Cambridge, UK). Activity was assessed by beam breaks. Beams were 1.25 cm apart and 
activity measurements were taken to be total beam breaks, rather than consecutive beam breaks. Any 
data from an animal whose weight changes in the calorimetry system were beyond those seen in the 
long-term home cage environment were excluded from analysis. At the end of the experiment animals 
were sacrificed and tissues collected for further analysis. 
Immunohistochemistry and histology. Animals were anesthetized with pentabarbitol (Dolethal) then 
transcardially perfused with 20 ml PBS followed by 40 ml 10% Formalin/PBS (Sigma). Brains were 
dissected out and incubated in 15% sucrose/10% Formalin overnight at 4oC. Following cryoprotection 
in 30% sucrose/PBS, brains were frozen on dry-ice and stored at -80oC overnight. Serial 35 μM sections 
were taken using a freezing microtome and mounted on glass slides (VWR).   
Laser capture microdissection and Q-RT-PCR of fed and 48hr fasted mouse brains. Laser-captured 
microdissection and total RNA isolation were carried out as previously described (7,8). 
Laser capture microdissection and RNA Sequencing of fed and fasted mouse brains. Coronal sections 
of 20 um thickness were prepared on a cryostat, mounted on RNase-free membrane-coated glass 
slides with laser microdissection performed using a P.A.L.M. MicrolaserSystem (P.A.L.M. Microlaser 
Technologies). 2ng of total RNA from each sample was SPIA (single primer isothermal amplification) 
amplified with an Ovation RNA-Seq System V2 (NuGEN), after which cDNA libraries were prepared 
using the Encore Rapid DR Multiplex System (NuGEN). Single-end reads (SE50) were sequenced on an 
Illumina Hi-Seq 2500. Reads were mapped to Mus Musculus GRCm38 genome assembly (Ensembl) 
with Tophat, and comparisons of fasted vs fed samples across the four hypothalamic were performed 
in RStudio using the edgeR and limma packages.    
RNA-Seq analysis of whole hypothalami from wildtype and Tmem18tm1a/tm1a mice.  The hypothalamus 
was dissected from 4 male adult mutant mice and 5 wild-type littermate controls. RNA was extracted 
using Qiagen RNeasy Mini Kit according to manufacturer’s instructions. 1 ug of RNA was used to 
prepare multiplexed sequencing libraries with an Illumina RNA Library Preparation Kits as per the 
manufacturer’s instructions. Paired end sequencing was performed on the Illumina Hi-Seq 2500, 
generating 75 bp, stranded paired-end reads.  Using STAR (v.2.4)(9) the sequenced reads were aligned 
to a modified version of the mouse reference genome (GRCm38) with addition of 
pseudo-chromosomes containing sequences of the knockout first conditional-ready allele (specifically, 
of the LacZ and neomycin regions of the cassette) for genotyping quality control . The number of reads 
that mapped to each annotated gene was counted using the HTSeq (v.0.6.1) count function 
(HTSeq.scripts.count, mode intersection-nonempty).  The DESeq2 package (v.1.9.29)(10) was used for 
differential gene expression analysis between mutant and wildtype mice, using the 
Benjamini-Hochberg procedure (to control for multiple testing, returning an adjusted p value (padj)).  
A significance cut-off of padj < 0.05 was used.  
Quantitative-RT-PCR. Q-RT-PCR was performed on whole hypothalami and brown adipose tissue 
(BAT).  Tissues were dissected from individual mice, snap frozen and stored at -80oC until processed. 
RNA was extracted using TriSure (Bioline) and reverse transcribed using Il-Prom-II reverse 
transcription system (Promega) according to manufacturer’s instructions. To assess Tmem18 
expression within the PVN following surgery micro-punches of the PVN from individual mice were 
obtained from fresh frozen brains. Accuracy of the micro-punches was confirmed with cresyl violet 
staining of the cryostat sections after nuclei removal. RNA was isolated from the micro-punch using 
the Qiagen RNeasy micro system and 50 ng of purified RNA were used in a random-primed first strand 
cDNA synthesis reaction, using the VILO reverse transcriptase kit (Invitrogen). Quantitative PCR 
reactions were performed in triplicate on an ABI 7900HT (Applied Biosystems) using ABI PCR master 
mix and commercially available Taqman probes, according to manufacturer’s protocols. All Q-RT-PCR 
data was normalised to Gapdh expression. 
Assessment of Targeting Due to the small size of TMEM18 (17kDa) and concerns that the addition of 
a large protein might impact on expression and function of TMEM18, the AAV-Tmem18 construct did 
not contain a GFP tag (27 kDa).  Therefore, to investigate targeting in the experimental groups, we 
used both IHC with a TMEM18 antibody (a custom made rabbit polyclonal anti-TMEM18 antibody 
(Eurogentec, Belgium), 1:500 dilution used in Supplementary Fig 9 B&C), plus PVN punch and Q-RT-
PCR (see above). The method of PVN punch and Q-RT-PCR to confirm over-expression within our 
discrete nuclei gave a numerical value (in this case +1.5 fold increase) that were counted as a ‘hit’.  If 
Tmem18 expression did not reach at least 1.5 fold above baseline (average Tmem18 expression levels 
of all GFP injected animals) then they were counted as a ‘miss’.  Animals that were confirmed as being 
a ‘miss’ were removed from our analysis. Of the 19 animals injected with AAV-T18, 4 were used for 
IHC analysis and Q-RT-PCR expression data were obtained from 14.  Of these fourteen,  10 showed 
increased levels of Tmem18 expression so were counted as a ‘hit’ , while 4 did not so were counted as 
a ‘miss’.  These four were discarded from further analysis. One final animal included in the AAV-T18 
group underwent PVN punch with satisfactory cresyl violet staining but insufficient material was 
generated to quantify mRNA.  This gave an overall Q-RT-PCR confirmed hit rate of 10/14 (71%).  Of 
the 15 animals injected with AAV-GFP, 4 were used for IHC analysis and Q RT-PCR expression data 
were obtained from the remaining 11 mice.   
Transient transfection and immunocytochemistry.  Cos7 cells were plated on four-well glass chamber 
slides (Nalge Nunc International) at 25,000 cells/ml; 16 h later, each well was transfected with 500 ng 
of plasmid DNA using Lipofectamine (Thermo Fisher Scientific). After 48 h at 37oC, cells were fixed in 
3.7% formaldehyde with either 0.2% TritonX100 for 10 mins at RT or 40 ug/ml Digitonin for 10 mins 
at 4oC.  After washing in PBS, cells were incubated O/N at 4oC with the appropriate primary antibody.  
The following morning, cells were washed in PBS and incubated with an appropriate secondary 
antibody conjugated to either a 488 or 594 fluorophore. After washing in PBS, coverslips were 
mounted using VectaShield hardset mounting media with DAPI (Vector Laboratories) and fluorescent 
cells detected using a Nikon Eclipse TE2000-U microscope. If colocalization of two proteins was being 
studied, before mounting with coverslips, cells were incubated with the second primary antibody at 
RT for 3hrs, washed in PBS then incubated with an appropriate secondary antibody conjugated to 
either a 488 or 594 fluorophore. Primary antibodies used were as follows: custom made rabbit-anti-
mouseTMEM18 antibody raised against amino acids 120-134; Rabbit Polyclonal FLAG tag (Sigma); 
Monoclonal Anti-FLAG M2 (Sigma), Rabbit-anti-human calnexin (ab22595, Abcam); Goat-anti-mouse 
lamin B (Santa Cruz Biotech, sc-6217) and Rabbit polyclonal Myc tag (Abcam, ab9106).   
Pulldown and Mass Spec analysis.  HEK293 cells were cultured in Dulbecco’s Modified Minimal 
Essential Medium (DMEM) supplemented with 10% FCS at 37oC under 5% CO2. For protein over 
expression studies, transient transfection in HEK293 cells was performed using a CalPhos kit according 
to the manufacturer’s protocol. 48 hours post transfection, cells were harvested and Flag 
immunoprecipitations (IPs) were performed from the resulting lysates as described (11). For MS 
analysis, Flag immunoprecipitates were subjected to SDS-PAGE, each lane was excised and cut into 6 
chunks with the proteins digested in-gel using trypsin. The resulting tryptic peptides were eluted and 
analysed by LC-MSMS using an LTQ-OrbiTrap XL (Thermo) coupled to a nanoAcquity (Waters) in a top 
6 DDA fashion. Raw files were processed using MaxQuant 1.3.0.5. Searches were performed using the 
Andromeda search engine against a Uniprot Mus musculus database (downloaded 14/08/12). 
Oxidation (M), acetylation (protein N-terminus) and deamidation (NQ) were set as variable 
modifications. Data was filtered to a peptide and protein FDR of 0.01. Validation of MS analysis results 
was performed as previously described  (11). 
Direct and Competitive Bimolecular Fluorescence Complementation.  YFP constructs and controls were 
a kind gift from David Savage (12). Interactions between YN-FLAG-NDC1/AAAS/NUP35 and MYC-
TMEM18-YC in COS-7 cells were assessed by transfecting 200 ng of each YN construct with 200 ng of 
each YC construct.  Four hours post transfection, cells were incubated at 32°C for 20hr and 30°C for 
2.5hr to promote the formation of YFP. Twenty-four hours post transfection, cells were fixed, 
permeabilized, and stained with anti-FLAG mouse monoclonal antibody (Sigma) followed by goat anti-
mouse Alexa 594 secondary antibody (Abcam). 
Bioinformatic Analysis. TMEM18 orthologues (144 sequences) from OMA database 
(http://omabrowser.org) were aligned with Muscle (13) and submitted to HHpred searches (14) in all 
available microbial fungal and metazoan protein databases and collections of HMM profiles using MPI 
Toolkit suite(15). The homology models were based on the HHpred alignments. The structures were 
displayed and examined with Protein Workshop Viewer (16). 
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Fig S1. Analysis of Tmem18 expression. RT-PCR analysis of Tmem18 expression in various
mouse tissues. GapDH was used as a positive control.
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Fig. S2. Validation of laser-capture microdissection specificity in ad libitum fed and 24hr
fasted wildtype mice. Bar charts showing FPKM values for genes known to be enriched in
given hypothalamic nuclei. White bars show fed mice, black bars show mice fasted for 24hrs.
Pomc, Agrp, Npy, Crh, Nr5a1, and Hcrt have expression specific to their corresponding
hypothalamic region (FDR<0.001). Upregulation of expression with fasting is evident in the
arcuate nucleus for Agrp (FDR = 0.001) and Npy (FDR = 0.017). PVN, paraventricular nucleus;
VMH, ventral medial hypothalamus; DMH, dorsal medial hypothalamus; ARC, arcuate nucleus,
Pomc, pro-opiomelanocortin; Agrp, agouti-related peptide; Cartpt, cocaine and amphetamine-
regulated transcript protein; Trh, thyrotropin releasing hormone; Crh, corticotropin releasing
hormone; Nr5a1, nuclear receptor subfamily 5 group A member 1; Hcrt, hypocretin
neuropeptide precursor.
*
*
Fig S3. Gene expression of Tmem18 in laser captured hypothalamic nuclei from ad libitum
fed and 24 hour fasted wildtype mice. White bars show fed mice, black bars show mice
fasted for 24hrs. PVN, paraventricular nucleus; VMH, ventral medial hypothalamus; DMH,
dorsal medial hypothalamus; ARC, arcuate nucleus. No significant difference between fed vs
fast in any nuclei.
Fig S4. Expression of genes neighbouring Tmem18 in laser captured hypothalamic nuclei from
ad libitum fed and 24 hour fasted wildtype mice. (A) Sh3yl1, (B) Acp1, (C) Sntg2. White bars
show fed mice, black bars show mice fasted for 24hrs. PVN, paraventricular nucleus; VMH, ventral
medial hypothalamus; DMH, dorsal medial hypothalamus; ARC, arcuate nucleus. For each gene,
no significant difference between fed vs fast in any nuclei.
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Fig S5. Validation of the Tmem18tm1a model. (A) Gene expression of Tmem18 in the
hypothalamus, cortex and kidney of WT (white bars), heterozygous (grey bars) and
homozygous (black bars) mice, normalised to expression of GAPDH. (B) Gene expression
of Tmem18 and its neighbouring genes Sh3yl1, Acp1 and Sntg2 in the hypothalamus of
WT, heterozygous and homozygous mice, normalised to expression of Gapdh. Data are
expressed as mean ± SEM *** p<0.001 vs WT mice.
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Fig S6. Effect of loss of expression of Tmem18 on body weight, length and composition in
female mice maintained either on a normal chow diet or 45% HFD. (A) Body weights of
Tmem18wt/wt (WT) and Tmem18tm1a/tm1a (HOM) female mice on normal chow. (B) Body
weights of WT and HOM female mice placed on a high fat diet (HFD) at 8 weeks of age. (C)
Body composition analyses showing total, lean or fat mass of 14-week old WT and HOM
female mice on normal chow. (D) Body composition analyses showing total, lean or fat mass
of 14-week old WT and HOM female mice placed on HFD at 8 weeks of age. (E) Weights of
gonadal white adipose tissue (gWAT) and brown adipose tissue (BAT) of WT and homozygous
mice at 18 weeks of age, normalised to body weight. (F) Weights of gonadal white adipose
tissue (gWAT) and brown adipose tissue (BAT) of 18-22 week old WT and homozygous mice
fed a HFD from 8 weeks of age normalised to body weight. Data are expressed as mean ±
SEM. WT mice are represented by white symbols and bars. HOM mice are represented by
black symbols and bars. Time-course data were analysed using the repeated measures
ANOVA model. p-values for C-F were calculated using a two-tailed distribution unpaired
Student’s t-test . No significant differences were seen between genotypes in any comparison.
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Fig S7 . Effect of loss of expression of Tmem18 on regional fat mass (A) Weights of gonadal
white adipose tissue (gWAT) and brown adipose tissue (BAT) of WT and homozygous mice at 18
weeks of age (WT, n=12; HOM, n=9). (B) Weights of gonadal white adipose tissue (gWAT) and
brown adipose tissue (BAT) of 18-22 week old WT and homozygous mice fed a HFD from 8
weeks of age (WT, n=15; HOM, n=20). Data are expressed as mean ± SEM. * p<0.05, ** p<0.01
vs WT mice.
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Fig S8. Effect of loss of expression of Tmem18 on BAT and activity levels and food intake
in male mice fed a HFD. (A) Q-RT-PCR analysis of Tmem18 and brown adipose tissue (BAT)
markers Ucp1, Elovl3 and Ppara expression in WT and HOM male mice (WT, n=7; HOM,
n=5). (B) Activity of WT and HOM mice during indirect calorimetry experiment represented
by beam breaks per minute during total time in cage, the day and at night (WT, n=13; HOM,
n=18). Data are expressed as mean ± SEM. *** p<0.001 vs WT mice.
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Fig S9. Overexpression of Tmem18 within the PVN. (A) Representative section showing discrete
GFP expression (green) within the PVN two weeks after unilateral AAV-GFP injection, with DAPI
staining shown in blue. 3V, 3rd ventricle.(B) Representative section showing IHC to confirm
discrete TMEM18 expression within the PVN two weeks after bilateral AAV-T18 injection. (C)
Representative sections showing IHC to detect TMEM18 protein expression within the PVN after
injection of either AAV-GFP (left) or AAV-T18 (right). (D) Percentage change in body weight of
mice placed on a high fat diet immediately after surgery and measured weekly for 6 weeks after
bi-lateral PVN injections with either an AAV-T18 cDNA or AAV-GFP (n= 6 each group). (E)
Average 24-hour energy intake of mice on HFD, measured in their home cage, 2 weeks
post-surgery (n= 6 each group). (F) Body composition analyses of mice on HFD showing total,
lean or fat mass at 6 weeks post surgery (n= 6 each group. Data are expressed as mean ± SEM, *
p<0.05, ** p<0.01, *** p<0.001 vs GFP injected mice.
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Fig S10. Tentative illustrative sketch of TMEM18 modelled 
as a tetramer. The individual monomers are displayed in 
different colours. The conserved C-terminus (~25 amino 
acids) is exposed to the cytoplasm and the upper four-
helix domain is embedded in the membrane with its N-
terminus pointing to the cytoplasm. The preceding 
sequence of ~50 amino acids is exposed to the cytoplasm 
but cannot be modelled due to the lack of homology.
Fig S11. Over-expression of N-terminal FLAG-
tagged TMEM18 in COS cells treated with either
TX-100 (permeabilises both plasma & nuclear
membrane) or digitonin (permeabilises plasma
membrane only). Lamin (A&B) and Calnexin (C&D)
are shown as controls.
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Fig S12. Effect of loss of Tmem18 on the hypothalamic transcriptome. (A) MA plot showing
differentially expressed genes in the hypothalami of Tmem18wt/wt and Tmem18tm1a/tm1a male
mice. Tmem18, the only gene with a statistically significant difference in expression, is shown
in red. The next two transcripts with the largest difference in expression (Hbb-bs and Banp)
are shown in green. Four additional genes selected for confirmatory analysis are shown in
black. (B) Q-RT-PCR analysis of selected genes in the hypothalami of Tmem18wt/wt and
Tmem18tm1a/tm1a male mice.

